Business


Camille Delebecque - Building Synthetic Biology Companies

Dr. Camille Delebecque, M.Sc., PhD is Co-Founder & CEO of Afineur, a company that sustainably processes raw agriculture into plant-based meats and optimizes the flavor profiles of various foods using the latest advances in fermentation & enzymology. He also operates two other companies: (1) SOIL.BIO (Founder & CEO), a startup that aims to develop proprietary mixtures of microbes that enrich the soil with nutrients and improve crop yields and (2) SynBio Consulting (Founder & Partner), where he works with companies, governmental institutions, universities, and investment funds to assist in the deployment of novel biotechnologies.

HBP-promo-0107.png
HBP-promo-0111.png
HBP-promo-0108.png
HBP-promo-0112.png
HBP-promo-0109.png
HBP-promo-0110.png

Elias Davis - Investing & Skill Building

Elias Davis is a Principal at Kli Capital, a generalist venture capital firm based out of New York City with a focus on investing in early-stage companies.

HBP-promo-0081.png
HBP-promo-0085.png
HBP-promo-0089.png
HBP-promo-0082.png
HBP-promo-0086.png
HBP-promo-0090.png
HBP-promo-0083.png
HBP-promo-0087.png
HBP-promo-0084.png
HBP-promo-0088.png

Ernesto Chanona - Business & Relationship Building

Ernesto Chanona, PhD is the Senior Manager in the Office of BioHealth and Life Sciences at the Maryland Department of Commerce, which fosters growth of life sciences business in the state of Maryland through a host of initiatives. Ernesto helps connect various institutions (NIH, biotech/pharma companies, etc.), individuals (inventors, entrepreneurs, etc.), and investors to facilitate economic development.

HBP-promo-0059.png
HBP-promo-0063.png
HBP-promo-0067.png
HBP-promo-0060.png
HBP-promo-0064.png
HBP-promo-0068.png
HBP-promo-0061.png
HBP-promo-0065.png
HBP-promo-0069.png
HBP-promo-0062.png
HBP-promo-0066.png

Lauren Lee - Biotech Investing

Lauren Lee, Ph.D is an Associate at Solasta Ventures, the U.S. subsidiary of South Korean venture capital firm Aju IB that focuses on investments in therapeutics and life science companies.

HBP-promo-0021.PNG
HBP-promo-0025.PNG
HBP-promo-0022.PNG
HBP-promo-0026.PNG
HBP-promo-0023.PNG
HBP-promo-0027.PNG
HBP-promo-0024.PNG
HBP-promo-0028.PNG

Sam Hong - Running a Pharmaceutical Startup

Sam Hong, Ph.D is the Chief Operating Officer (COO) at Rapafusyn Pharmaceuticals, a pre-clinical stage startup developing macrocycle-based therapeutics for treatment of various disease indications.

HBP-promo-0008.PNG
HBP-promo-0011.PNG
HBP-promo-0005.PNG
HBP-promo-0009.PNG
HBP-promo-0010.PNG